Skip to content

Studying the role of homoeopathic medicines in reducing aggression in mentally challenged children using diffrent scales

A pilot study to assess the role of homoeopathic medicines in reducing aggression in mentally challenged children using modified overt aggression scale and outcome related impact on daily living

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048978
Enrollment
30
Registered
2023-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F988- Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence

Interventions

Intervention1: Homoeopathic medicines: Dose: it will vary according to the case from 30 potency upto CM or LM etc potency. Frequency: it will differ according to the case OD or BD or TDS or QID etc. R

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients parent/guardian ready to sign assent form

Exclusion criteria

Exclusion criteria: 1 cases where severe pathology is involved 2 cases with endocrinal involvement

Design outcomes

Primary

MeasureTime frame
The administered homoeopathic medicine is effective in reducing aggression in mentally challenged children. This will be assessed using modified overt aggression scale and outcome related impact on daily living.Timepoint: Reducing the aggression in mentally challenged children by assessing the modified overt aggression scale and outcome related impact on daily living at an interval of every 2 months and children will be followed up after every 15 days.

Secondary

MeasureTime frame
Improving the behavior of mentally challenged children by the administered homoeopathic medicine.Timepoint: Children will be followed up after every 15 days. The modified overt aggression scale and outcome related impact on daily living will be assessed at an interval of every 2 months.

Countries

India

Contacts

Public ContactDr Anita S Patil

Bharati Vidyapeeth Deemed to be University Homoeopathic Medical college & Hospital

anita.patil@bharatividyapeeth.edu9657729907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026